Jing Li

Title: Innovations of Jing Li in Pharmaceutical Composition

Introduction

Jing Li is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that aid in treating gastrointestinal conditions. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Jing Li holds a patent for a pharmaceutical composition containing ilaprazole or a salt thereof, along with a preparation method for this composition. The patent describes a formulation that includes ilaprazole or its derivatives, with the ilaprazole derivative not exceeding 1.3 wt %. This composition is particularly useful for treating peptic ulcer bleeding and stress ulcers, as well as preventing upper gastrointestinal hemorrhage caused by severe diseases. Jing Li's patent is a testament to his commitment to advancing medical treatments.

Career Highlights

Jing Li is associated with Livzon Pharmaceutical Group Co., Ltd., where he has been instrumental in research and development. His work has not only contributed to the company's portfolio but has also had a positive impact on patient care through innovative pharmaceutical solutions. His dedication to improving health outcomes is evident in his research endeavors.

Collaborations

Jing Li collaborates with talented professionals in his field, including colleagues such as Tao Wang and Xuemei Hou. These collaborations enhance the research environment and foster innovation within the pharmaceutical industry.

Conclusion

Jing Li's contributions to pharmaceutical innovation, particularly through his patent on ilaprazole compositions, highlight his role as a key inventor in the field. His work continues to influence the development of effective treatments for gastrointestinal conditions.